Glenn R. Mattes, President and CEO at TFF Pharmaceuticals, Inc. (TFFP), bought 10,000 shares at $5.00 ($50K) on 2019-10-25, disclosed to the SEC on 2019-10-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| TFFP | SELL | 2021-03-17 | $852K | — | Filing → |
| TFFP | SELL | 2021-02-18 | $673K | — | Filing → |
| TFFP | SELL | 2021-01-20 | $1.5M | — | Filing → |